Form D · Pharmaceuticals
Appling Enterprises, LLC
Denton, TX · CIK 0001729692
Offering snapshot reported Jan 30, 2018 · SEC filing
- Reported sold
- $700K Offering amount: $700K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 8, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 30, 2018 | Initial | $700,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-304365
Source: Form D, filed Jan 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Appling | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2501 W. Oak Street, Suite 100
Denton, TX, 76201
Denton, TX, 76201